• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗时代前医护人员中 SARS-CoV-2 抗体的血清流行率:系统评价和荟萃分析。

The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.

机构信息

Koç University, School of Medicine, Department of Public Health, Istanbul, Turkey.

Koç University, School of Nursing, Department of Public Health, Istanbul, Turkey.

出版信息

Clin Microbiol Infect. 2021 Sep;27(9):1242-1249. doi: 10.1016/j.cmi.2021.05.036. Epub 2021 Jun 8.

DOI:10.1016/j.cmi.2021.05.036
PMID:34116205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8186944/
Abstract

BACKGROUND

The prevalence of SARS-CoV-2 infection among health care workers (HCWs) provides information about the spread of COVID-19 within health care facilities, and the risk groups.

OBJECTIVES

We aimed to describe the rate of SARS-CoV-2 seroprevalence and its determinants among HCWs.

DATA SOURCES

We used Web of Science, PubMed, Scopus, MEDLINE, EBSCOhost and Cochrane Library.

STUDY ELIGIBILITY CRITERIA

We included the reports of SARS-CoV-2 seroprevalence with a sample size of minimum 1000 HCWs.

METHODS

The study was registered at the International Prospective Register of Systematic Reviews (PROSPERO, no. CRD42021230456). We used PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The keywords were "COVID-19", "SARS-CoV-2", "Coronavirus", "seroprevalence", "health care workers" and "risk factors".

RESULTS

In total 4329 reports were retrieved, duplications were removed; after filtering according to the title and abstract, 25 studies were selected. Risk of bias was assessed in 25 studies; it was low in 13 studies, medium in four studies, and high in eight studies. In meta-analysis using the random effect model, the weighted average of seroprevalence was calculated as 8% (95% CI 6-10%). The pooled seroprevalence rates of the selected variables that have a rate above the average were male HCWs with 9% (95% CI 7-11%); HCWs from ethnic minorities with 13% (95% CI 9-17%); high exposure 9% (95% CI 6-13%); exposure to the virus outside the health care setting 22% (95% CI 14-32%).

CONCLUSIONS

Our analysis indicates a SARS-CoV-2 seroprevalence rate of 8% among studies that included >1000 HCWs for the year 2020, before vaccinations started. The most common risk factors associated with higher seroprevalence rate were ethnicity, male gender and having a higher number of household contacts. Working as a frontline HCW was inconsistent in its association with higher seroprevalence.

摘要

背景

医护人员(HCWs)中 SARS-CoV-2 感染的流行情况提供了有关 COVID-19 在医疗机构内传播和风险群体的信息。

目的

我们旨在描述 HCWs 中 SARS-CoV-2 血清流行率及其决定因素。

数据来源

我们使用了 Web of Science、PubMed、Scopus、MEDLINE、EBSCOhost 和 Cochrane Library。

研究入选标准

我们纳入了 SARS-CoV-2 血清流行率报告,样本量最小为 1000 名 HCWs。

方法

该研究在国际前瞻性系统评价注册库(PROSPERO,编号:CRD42021230456)中进行。我们使用 PRISMA(系统评价和荟萃分析的首选报告项目)声明。关键词为“COVID-19”、“SARS-CoV-2”、“冠状病毒”、“血清流行率”、“医护人员”和“危险因素”。

结果

共检索到 4329 篇报告,剔除重复项;根据标题和摘要进行筛选后,选择了 25 项研究。25 项研究均进行了偏倚风险评估;其中 13 项研究的偏倚风险较低,4 项研究的偏倚风险为中等,8 项研究的偏倚风险较高。采用随机效应模型进行荟萃分析,计算出加权平均血清流行率为 8%(95%CI 6-10%)。选择的变量的汇总血清流行率高于平均值,包括男性 HCWs 的 9%(95%CI 7-11%);少数民族 HCWs 的 13%(95%CI 9-17%);高暴露率的 9%(95%CI 6-13%);在医疗机构外接触病毒的 22%(95%CI 14-32%)。

结论

我们的分析表明,在接种疫苗之前的 2020 年,纳入了>1000 名 HCWs 的研究中,SARS-CoV-2 血清流行率为 8%。与较高血清流行率相关的最常见危险因素是种族、男性和更多的家庭接触者。作为一线 HCW 与较高的血清流行率之间的关联并不一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/61186779c747/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/95704e9e4026/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/271d86357a3b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/0cd871af5434/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/61186779c747/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/95704e9e4026/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/271d86357a3b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/0cd871af5434/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c231/8186944/61186779c747/gr4_lrg.jpg

相似文献

1
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.疫苗时代前医护人员中 SARS-CoV-2 抗体的血清流行率:系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Sep;27(9):1242-1249. doi: 10.1016/j.cmi.2021.05.036. Epub 2021 Jun 8.
2
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.医护人员中 SARS-CoV-2 抗体的血清流行率及相关因素:系统评价和荟萃分析。
J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16.
3
Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.护士人群中 SARS-CoV-2 抗体的流行率:一项系统评价和荟萃分析。
J Clin Nurs. 2022 Jun;31(11-12):1557-1569. doi: 10.1111/jocn.16009. Epub 2021 Sep 27.
4
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.欧洲、美国和东亚医护人员在接种疫苗前SARS-CoV-2 IgG抗体的血清流行率:一项系统评价和荟萃分析。
EClinicalMedicine. 2021 Mar;33:100770. doi: 10.1016/j.eclinm.2021.100770. Epub 2021 Mar 8.
5
Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.八个国家儿科医疗机构医护人员中 SARS-CoV-2 抗体的横断面患病率。
J Hosp Infect. 2021 Apr;110:60-66. doi: 10.1016/j.jhin.2020.12.019. Epub 2021 Jan 7.
6
SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.印度克什米尔地区不同工作场所暴露风险的医护人员中 SARS-CoV-2 血清流行率。
J Hosp Med. 2021 May;16(5):274-281. doi: 10.12788/jhm.3609.
7
Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.SARS-CoV-2 抗体的血清阳性率以及 6 个月内降低再感染风险:一项针对 44000 名医护人员的丹麦观察性队列研究。
Clin Microbiol Infect. 2022 May;28(5):710-717. doi: 10.1016/j.cmi.2021.09.005. Epub 2021 Sep 17.
8
SARS-CoV-2 seroprevalence among healthcare workers.SARS-CoV-2 血清抗体阳性率在医护人员中的情况。
PLoS One. 2022 Apr 25;17(4):e0266410. doi: 10.1371/journal.pone.0266410. eCollection 2022.
9
Risk factors for COVID-19 among healthcare workers. A protocol for a systematic review and meta-analysis.医护人员中新型冠状病毒肺炎的危险因素。一项系统评价与荟萃分析方案。
PLoS One. 2021 May 4;16(5):e0250958. doi: 10.1371/journal.pone.0250958. eCollection 2021.
10
Seroprevalence of Covid-19 infection among healthcare workers: A study from a tertiary care hospital in the National Capital Region of India.印度国家首都地区一家三级护理医院医护人员中新冠病毒感染的血清流行率:一项研究
Natl Med J India. 2022 Jul-Aug;35(4):219-220. doi: 10.25259/NMJI_345_21.

引用本文的文献

1
SARS-CoV-2 Antibody Prevalence Across Unvaccinated Health Care Workers During the COVID-19 Pandemic in Yemen: Cross-Sectional Study.也门新冠疫情期间未接种疫苗医护人员中新冠病毒2型抗体流行情况:横断面研究
JMIR Public Health Surveill. 2025 Aug 29;11:e67296. doi: 10.2196/67296.
2
SCORE: Serologic evidence of COVID-19 and social and occupational contacts in healthcare workers in long-term care and acute care facilities in Southeastern Ontario (SCORE).SCORE:安大略省东南部长期护理和急症护理机构医护人员中COVID-19的血清学证据以及社交和职业接触情况(SCORE)。
PLoS One. 2025 Aug 13;20(8):e0303813. doi: 10.1371/journal.pone.0303813. eCollection 2025.
3

本文引用的文献

1
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性:系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
2
Mitigating ethnic disparities in covid-19 and beyond.缓解新冠疫情及其他情况下的种族差异。
BMJ. 2021 Jan 14;372:m4921. doi: 10.1136/bmj.m4921.
3
COVID-19 and healthcare workers: A systematic review and meta-analysis.
Antibody Responses to SARS-CoV-2 among Health Care Workers in North-Eastern Tanzania.
坦桑尼亚东北部医护人员对新冠病毒的抗体反应
East Afr Health Res J. 2024;8(3):305-314. doi: 10.24248/eahrj.v8i3.799. Epub 2025 Jan 30.
4
Seroprevalence of SARS-CoV-2 antibodies among oral health care workers with natural seroconversion: a systematic review and meta-analysis.自然血清转化的口腔医护人员中SARS-CoV-2抗体的血清流行率:一项系统评价和荟萃分析。
Sci Rep. 2025 Mar 6;15(1):7848. doi: 10.1038/s41598-025-91529-4.
5
A multi-site cross-sectional study on the burden of SARS-CoV-2 in healthcare workers in Madagascar.马达加斯加医护人员中 SARS-CoV-2 负担的多地点横断面研究。
PLoS One. 2024 Oct 24;19(10):e0309977. doi: 10.1371/journal.pone.0309977. eCollection 2024.
6
Predictors of seropositivity to SARS-CoV-2 among employees at a large urban medical center.大型城市医疗中心员工中对 SARS-CoV-2 血清阳性的预测因素。
BMC Public Health. 2024 Oct 9;24(1):2754. doi: 10.1186/s12889-024-20274-6.
7
Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Healthcare Personnel in El Salvador Prior to Vaccination Campaigns.萨尔瓦多疫苗接种运动开展前医护人员中抗SARS-CoV-2 IgG抗体的血清流行率
Infect Dis Rep. 2024 Jun 7;16(3):531-542. doi: 10.3390/idr16030040.
8
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave.法国第三次 COVID-19 浪潮后,初级保健工作者中 SARS-CoV-2 感染的流行情况及相关因素。
Sci Rep. 2024 Mar 5;14(1):5418. doi: 10.1038/s41598-024-55477-9.
9
High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors.喀麦隆雅温得医护人员在第一波 COVID-19 大流行后严重急性呼吸综合征冠状病毒 2 的高血清阳性率及相关因素。
Influenza Other Respir Viruses. 2024 Feb;18(2):e13239. doi: 10.1111/irv.13239.
10
Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.荷兰医院医护人员在 2020 年第一波疫情后 SARS-CoV-2 抗体的血清阳性率:一项前瞻性随访的多中心横断面研究。
Antimicrob Resist Infect Control. 2023 Nov 29;12(1):137. doi: 10.1186/s13756-023-01324-x.
COVID-19 与医护人员:系统评价与荟萃分析。
Int J Infect Dis. 2021 Mar;104:335-346. doi: 10.1016/j.ijid.2021.01.013. Epub 2021 Jan 11.
4
Occupational COVID-19 risk for anaesthesia and intensive care staff - low-risk specialties in a high-risk setting.麻醉和重症监护人员的职业性新冠病毒风险——高风险环境中的低风险专业
Anaesthesia. 2021 Mar;76(3):295-300. doi: 10.1111/anae.15358. Epub 2020 Dec 11.
5
SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.新型冠状病毒2型疫苗接种——一盎司(实际上远少于此)的预防措施。
N Engl J Med. 2020 Dec 31;383(27):2677-2678. doi: 10.1056/NEJMe2034717. Epub 2020 Dec 10.
6
Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review.全球 COVID-19 医护人员的感染和死亡率:系统综述。
BMJ Glob Health. 2020 Dec;5(12). doi: 10.1136/bmjgh-2020-003097.
7
SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis.北布里斯托尔国民保健服务信托基金医护人员及其他工作人员中新型冠状病毒2型IgG血清流行率:一项社会人口学分析。
J Infect. 2021 Mar;82(3):e24-e27. doi: 10.1016/j.jinf.2020.11.036. Epub 2020 Dec 1.
8
Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19.在 COVID-19 负担较低的国家,医护人员中的 SARS-CoV-2 抗体。
PLoS One. 2020 Dec 3;15(12):e0243025. doi: 10.1371/journal.pone.0243025. eCollection 2020.
9
Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review.COVID-19 相关感染、住院和死亡的种族和民族差异:系统评价。
Ann Intern Med. 2021 Mar;174(3):362-373. doi: 10.7326/M20-6306. Epub 2020 Dec 1.
10
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.全球范围内 SARS-CoV-2 血清流行率:系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Mar;27(3):331-340. doi: 10.1016/j.cmi.2020.10.020. Epub 2020 Oct 24.